Figure 2.
EFS and OS for the entire ITT cohort, according to treatment group. Kaplan-Meier projections for EFS (A), defined as freedom from primary refractory disease, initial onset of progression, relapse after a response, death from any cause, or the development of a second cancer; and OS (B), defined as freedom of death from any cause. The shaded area illustrates the 95% CIs.